echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Rheumatology: Prevalence of undiagnosed axial spondylitis in IBD patients with chronic back pain, a cross-sectional study in secondary care

    Rheumatology: Prevalence of undiagnosed axial spondylitis in IBD patients with chronic back pain, a cross-sectional study in secondary care

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    OBJECTIVE: To elucidate the prevalence of rheumatologist-verified diagnosis of axial spondyloarthritis (RVD-axSpA) in patients with chronic back pain presenting to routine secondary inflammatory bowel disease (IBD) outpatient clinics prevalence


    METHODS: A screening questionnaire was sent to consecutive patients at the IBD clinic of a university teaching hospital and included for rheumatology evaluation in the following population—patients who met eligibility criteria (diagnosed by a gastroenterologist, 18-80 years old, no Receiving biological therapy, no prior axSpA diagnosis); population with moderate probability of axSpA diagnosis [self-reported chronic back pain (CBP) >3 months, onset <45 years]


    Contents include medical review, physical examination, patient-reported outcome measures, human leukocyte antigen B27, C-reactive protein, pelvic radiographs, and axSpA protocol magnetic resonance imaging


    RESULTS: Of the 470 patients contacted, 91 had self-reported CBP >3 months and onset <45 years, of whom 82 were eligible for clinical evaluation


    For patients with undiagnosed RVD axSpA (self-reported CBP, incidence <45 years) attending an IBD clinic in a secondary care facility, the prevalence was estimated at 5% (95% CI 1.


    Conclusions: There is a significant axSpA recessive disease burden in IBD patients


     

    Source:

    Lim CSE, Tremelling M, Hamilton L, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.